Cargando…

Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer

Purpose: To assess the optimal planning target volume (PTV) margins for stereotactic body radiotherapy (SBRT) of prostate cancer based on inter- and intra-fractional prostate motion determined from daily image guidance. Methods and Materials: Two hundred and five patients who were enrolled on two pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Levin-Epstein, Rebecca, Qiao-Guan, George, Juarez, Jesus E., Shen, Zhouhuizi, Steinberg, Michael L., Ruan, Dan, Valle, Luca, Nickols, Nicholas G., Kupelian, Patrick A., King, Christopher R., Cao, Minsong, Kishan, Amar U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177009/
https://www.ncbi.nlm.nih.gov/pubmed/32373529
http://dx.doi.org/10.3389/fonc.2020.00539
_version_ 1783525124732878848
author Levin-Epstein, Rebecca
Qiao-Guan, George
Juarez, Jesus E.
Shen, Zhouhuizi
Steinberg, Michael L.
Ruan, Dan
Valle, Luca
Nickols, Nicholas G.
Kupelian, Patrick A.
King, Christopher R.
Cao, Minsong
Kishan, Amar U.
author_facet Levin-Epstein, Rebecca
Qiao-Guan, George
Juarez, Jesus E.
Shen, Zhouhuizi
Steinberg, Michael L.
Ruan, Dan
Valle, Luca
Nickols, Nicholas G.
Kupelian, Patrick A.
King, Christopher R.
Cao, Minsong
Kishan, Amar U.
author_sort Levin-Epstein, Rebecca
collection PubMed
description Purpose: To assess the optimal planning target volume (PTV) margins for stereotactic body radiotherapy (SBRT) of prostate cancer based on inter- and intra-fractional prostate motion determined from daily image guidance. Methods and Materials: Two hundred and five patients who were enrolled on two prospective studies of SBRT (8 Gy × 5 fractions) for localized prostate cancer treated at a single institution between 2012 and 2017 had complete inter- and intra-fractional shift data available. All patients had scheduled kilovoltage planar imaging during SBRT with rigid registration to intraprostatic fiducials prior to each of four half-arcs delivered per fraction, as well as cone beam CT verification of anatomy prior to each fraction. Inter- and intra- fractional shift data were obtained to estimate the required PTV margins based on the classic van Herk formula. Inter- and intra-fractional motion were compared between patients with and without severe toxicities using the independent two-sample Wilcoxon test. Results: The margins required to account for inter-fractional motion were estimated to be 0.99, 1.52, and 1.45 cm in lateral (LR), longitudinal (SI), and vertical (AP) directions, respectively. The margins required to account for intra-fractional motion were estimated to be 0.19, 0.27, and 0.31 cm in LR, SI and AP directions, respectively. Large intra-fractional shifts were mostly observed in the SI and AP directions, with 2.0 and 5.4% of patients experiencing average intra-fractional motion >3 mm in the SI and AP directions, respectively, compared with none experiencing mean shifts >3 mm in the LR direction. Six patients experienced grade 3 gastrointestinal or genitourinary toxicity. There were no significant differences in mean inter- or intra-fractional motion in any of the cardinal directions compared to patients without severe toxicity (inter-fractional p = 0.46–0.99, intra-fractional p = 0.10–0.84). Conclusion: The inter- and intra-fractional margins estimated from this study are in line with prior reported values. Intra-fractional prostate motion was generally small with larger margins required for the SI and AP directions, notably just slightly exceeding the commonly used 3 mm posterior PTV margin even with realignment between half-arcs. Development of severe toxicity was not significantly associated with the degree of inter- or intra-fractional motion.
format Online
Article
Text
id pubmed-7177009
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71770092020-05-05 Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer Levin-Epstein, Rebecca Qiao-Guan, George Juarez, Jesus E. Shen, Zhouhuizi Steinberg, Michael L. Ruan, Dan Valle, Luca Nickols, Nicholas G. Kupelian, Patrick A. King, Christopher R. Cao, Minsong Kishan, Amar U. Front Oncol Oncology Purpose: To assess the optimal planning target volume (PTV) margins for stereotactic body radiotherapy (SBRT) of prostate cancer based on inter- and intra-fractional prostate motion determined from daily image guidance. Methods and Materials: Two hundred and five patients who were enrolled on two prospective studies of SBRT (8 Gy × 5 fractions) for localized prostate cancer treated at a single institution between 2012 and 2017 had complete inter- and intra-fractional shift data available. All patients had scheduled kilovoltage planar imaging during SBRT with rigid registration to intraprostatic fiducials prior to each of four half-arcs delivered per fraction, as well as cone beam CT verification of anatomy prior to each fraction. Inter- and intra- fractional shift data were obtained to estimate the required PTV margins based on the classic van Herk formula. Inter- and intra-fractional motion were compared between patients with and without severe toxicities using the independent two-sample Wilcoxon test. Results: The margins required to account for inter-fractional motion were estimated to be 0.99, 1.52, and 1.45 cm in lateral (LR), longitudinal (SI), and vertical (AP) directions, respectively. The margins required to account for intra-fractional motion were estimated to be 0.19, 0.27, and 0.31 cm in LR, SI and AP directions, respectively. Large intra-fractional shifts were mostly observed in the SI and AP directions, with 2.0 and 5.4% of patients experiencing average intra-fractional motion >3 mm in the SI and AP directions, respectively, compared with none experiencing mean shifts >3 mm in the LR direction. Six patients experienced grade 3 gastrointestinal or genitourinary toxicity. There were no significant differences in mean inter- or intra-fractional motion in any of the cardinal directions compared to patients without severe toxicity (inter-fractional p = 0.46–0.99, intra-fractional p = 0.10–0.84). Conclusion: The inter- and intra-fractional margins estimated from this study are in line with prior reported values. Intra-fractional prostate motion was generally small with larger margins required for the SI and AP directions, notably just slightly exceeding the commonly used 3 mm posterior PTV margin even with realignment between half-arcs. Development of severe toxicity was not significantly associated with the degree of inter- or intra-fractional motion. Frontiers Media S.A. 2020-04-16 /pmc/articles/PMC7177009/ /pubmed/32373529 http://dx.doi.org/10.3389/fonc.2020.00539 Text en Copyright © 2020 Levin-Epstein, Qiao-Guan, Juarez, Shen, Steinberg, Ruan, Valle, Nickols, Kupelian, King, Cao and Kishan. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Levin-Epstein, Rebecca
Qiao-Guan, George
Juarez, Jesus E.
Shen, Zhouhuizi
Steinberg, Michael L.
Ruan, Dan
Valle, Luca
Nickols, Nicholas G.
Kupelian, Patrick A.
King, Christopher R.
Cao, Minsong
Kishan, Amar U.
Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer
title Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer
title_full Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer
title_fullStr Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer
title_full_unstemmed Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer
title_short Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer
title_sort clinical assessment of prostate displacement and planning target volume margins for stereotactic body radiotherapy of prostate cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177009/
https://www.ncbi.nlm.nih.gov/pubmed/32373529
http://dx.doi.org/10.3389/fonc.2020.00539
work_keys_str_mv AT levinepsteinrebecca clinicalassessmentofprostatedisplacementandplanningtargetvolumemarginsforstereotacticbodyradiotherapyofprostatecancer
AT qiaoguangeorge clinicalassessmentofprostatedisplacementandplanningtargetvolumemarginsforstereotacticbodyradiotherapyofprostatecancer
AT juarezjesuse clinicalassessmentofprostatedisplacementandplanningtargetvolumemarginsforstereotacticbodyradiotherapyofprostatecancer
AT shenzhouhuizi clinicalassessmentofprostatedisplacementandplanningtargetvolumemarginsforstereotacticbodyradiotherapyofprostatecancer
AT steinbergmichaell clinicalassessmentofprostatedisplacementandplanningtargetvolumemarginsforstereotacticbodyradiotherapyofprostatecancer
AT ruandan clinicalassessmentofprostatedisplacementandplanningtargetvolumemarginsforstereotacticbodyradiotherapyofprostatecancer
AT valleluca clinicalassessmentofprostatedisplacementandplanningtargetvolumemarginsforstereotacticbodyradiotherapyofprostatecancer
AT nickolsnicholasg clinicalassessmentofprostatedisplacementandplanningtargetvolumemarginsforstereotacticbodyradiotherapyofprostatecancer
AT kupelianpatricka clinicalassessmentofprostatedisplacementandplanningtargetvolumemarginsforstereotacticbodyradiotherapyofprostatecancer
AT kingchristopherr clinicalassessmentofprostatedisplacementandplanningtargetvolumemarginsforstereotacticbodyradiotherapyofprostatecancer
AT caominsong clinicalassessmentofprostatedisplacementandplanningtargetvolumemarginsforstereotacticbodyradiotherapyofprostatecancer
AT kishanamaru clinicalassessmentofprostatedisplacementandplanningtargetvolumemarginsforstereotacticbodyradiotherapyofprostatecancer